林业机械与木工设备
林業機械與木工設備
임업궤계여목공설비
FORESTRY MACHINERY & WOODWORKING EQUIPMENT
2015年
4期
19-22
,共4页
结构用集成材%玻璃纤维增强树脂%胶合性能%等离子体处理%羟甲基间苯二酚
結構用集成材%玻璃纖維增彊樹脂%膠閤性能%等離子體處理%羥甲基間苯二酚
결구용집성재%파리섬유증강수지%효합성능%등리자체처리%간갑기간분이분
glulam%glass-fiber reinforced polymer%bonding properties%plasma treatment%hydroxymethyl resorcinol
FRP增强结构用集成材木梁可有效地提升梁体的抗弯强度,FRP与结构用集成材的复合首先要解决的是FRP与木材的胶合问题。本试验对比等离子体处理及羟甲基间苯二酚HMR改性处理工艺对FRP木材界面胶合性能的影响,并用胶层剥离率、剪切强度对胶合性能加以表征。试验结果表明,FRP增强结构用集成材木梁的胶合界面优化处理工艺为:FRP表面不处理,木材表面预先以2.5 m/min的送料速度进行射频功率为400 W的等离子体处理5次,然后以150 g/m2的涂胶量涂布HMR。试材的浸渍剥离率、煮沸剥离率、干剪强度、湿剪强度及木破率均满足结构用集成材国家标准GB/T 26899-2011中关于使用环境3的要求。
FRP增彊結構用集成材木樑可有效地提升樑體的抗彎彊度,FRP與結構用集成材的複閤首先要解決的是FRP與木材的膠閤問題。本試驗對比等離子體處理及羥甲基間苯二酚HMR改性處理工藝對FRP木材界麵膠閤性能的影響,併用膠層剝離率、剪切彊度對膠閤性能加以錶徵。試驗結果錶明,FRP增彊結構用集成材木樑的膠閤界麵優化處理工藝為:FRP錶麵不處理,木材錶麵預先以2.5 m/min的送料速度進行射頻功率為400 W的等離子體處理5次,然後以150 g/m2的塗膠量塗佈HMR。試材的浸漬剝離率、煮沸剝離率、榦剪彊度、濕剪彊度及木破率均滿足結構用集成材國傢標準GB/T 26899-2011中關于使用環境3的要求。
FRP증강결구용집성재목량가유효지제승량체적항만강도,FRP여결구용집성재적복합수선요해결적시FRP여목재적효합문제。본시험대비등리자체처리급간갑기간분이분HMR개성처리공예대FRP목재계면효합성능적영향,병용효층박리솔、전절강도대효합성능가이표정。시험결과표명,FRP증강결구용집성재목량적효합계면우화처리공예위:FRP표면불처리,목재표면예선이2.5 m/min적송료속도진행사빈공솔위400 W적등리자체처리5차,연후이150 g/m2적도효량도포HMR。시재적침지박리솔、자비박리솔、간전강도、습전강도급목파솔균만족결구용집성재국가표준GB/T 26899-2011중관우사용배경3적요구。
FRP reinforced structural glulam beams can effectively improve the bending mechanical strength performance of beam body. By comparing the effect of plasma treatment process and Hydroxymethyl resorcinol HMR modification treatment process on the bonding properties of FRP timber interface,layer peeling rate and shear strength are used to characterize bonding properties. The test result shows that the glued interface optimization process of FRP reinforced structural glulam beams is: FRP didn't accept any surface treatment. However,wood surface was treated by plasma at the speed of 2.5m/min and 400 watts 5 times before coating of hydroxymethyl resorcinol,150 g/m2. All evaluation indices such as immersion and boiling delamination percentage,dry and wet state shear strength and wood failure percentage meet the requirements of Ser-vice Environment Class 3 prescribed in GB/T 26899-2011.